| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 3,350 | 3,385 | 3,463 | 3,585 | | Cost of Revenue | 852 | 953 | 1,001 | 1,060 | | | Gross Profit |
-
| 2,432 | 2,462 | 2,525 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,021 | 1,920 | 1,707 | 1,766 | | Non Recurring | (42) | 42 | 151 |
-
| | Others |
-
|
-
| (1) |
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 470 | 605 | 759 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 519 | 470 | 605 | 759 | | Interest Expense | 121 | 136 | 151 | 170 | | Income Before Tax | 398 | 334 | 454 | 589 | | Income Tax Expense | 96 | 102 | 149 | 202 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 302 | 232 | 305 | 387 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 302 | 232 | 305 | 387 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $302 | $232 | $305 | $387 |
|
0.51% Nasdaq 
Income Statement
